Episode

Part 2 - Hypertrophic Cardiomyopathy: Hidden in Plain Sight

Podcast
DoctoRx Unscripted
Published
Feb 25, 2026
Duration seconds
3184
Processing state
not_requested
Canonical source
https://doctorx-unscripted.podbean.com/e/part-2-hypertrophic-cardiomyopathy-hidden-in-plain-sight-the-shift/
Audio
https://mcdn.podbean.com/mf/web/zg8g67y6fsf3n9ed/BMS_DRXU_CV_Part2_Ep_8_V43_AUDIO_022326bkwm1.mp3
JSON
/v1/public/podcasts/doctorx-unscripted-7398035/episodes/part-2-hypertrophic-cardiomyopathy-hidden-in-plain-sight
Markdown
/podcast/doctorx-unscripted-7398035/part-2-hypertrophic-cardiomyopathy-hidden-in-plain-sight.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/doctorx-unscripted-7398035/episodes/part-2-hypertrophic-cardiomyopathy-hidden-in-plain-sight/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/doctorx-unscripted-7398035/part-2-hypertrophic-cardiomyopathy-hidden-in-plain-sight.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for a special edition of DoctoRx Unscripted, focused on hypertrophic cardiomyopathy (HCM)—one of the most common inherited cardiac diseases and one of the most frequently missed. In Part 2, Dr. Small welcomes HCM expert Dr. Matthew Martinez and leading cardiologist Dr. Nani Bhalla. Together, they examine why hypertrophic cardiomyopathy has historically been so difficult to detect—and what has changed in recent years to begin altering that trajectory. The discussion explores how earlier recognition, paired with more precise and individualized treatment decisions, can change outcomes in meaningful and lasting ways.